Pharmafile Logo
Pharmafocus logo
Advanced Search

generics

Showing 15 posts of 209 posts found.

Adapt or die

December 2, 2009
Manufacturing and Production competition, generics, industry, pa consulting

For years, healthcare has been one of the most profitable sectors in industry. However the world is changing, and fast.Generics …

Feature

GSK returns to growth despite US sales hit

October 28, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …

News

Johnson & Johnson rides out patent attack

October 16, 2009
Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …

News

Hospira takes charge of biogeneric Neupogen

October 14, 2009
Sales and Marketing Hospira, biosimilars, generics

US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …

News

CambReg and SIRO forge strategic alliance

September 21, 2009
Sales and Marketing generics

UK contract research organisation Cambridge Regulatory Services has teamed up with one of its Indian counterparts – SIRO Clinpharm – …

News

Cipla plans push into biosimilars

September 10, 2009
Sales and Marketing biosimilars, generics

Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …

News

Authorised generics deals likely here to stay, says analyst

August 12, 2009
Research and Development, Sales and Marketing generics

The practice of branded drugmakers paying rivals to keep generics off the market after product patent expiry – known as …

News

Pfizer agrees price cut in Clinton deal

August 7, 2009
Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009
Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …

News

Europe launches pharma competition crackdown

July 8, 2009
Research and Development Europe, generics

The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …

News

Novartis gains approval for first Japanese biosimilar

June 25, 2009
Research and Development, Sales and Marketing Novartis, generics

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …

News
Abbas Hussain

GSK to co-market generics with Dr. Reddy’s

June 17, 2009
Sales and Marketing Dr Reddy, GSK, em, generics

 GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …

News

Battle ahead for US industry over biologics patents

June 12, 2009
Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform

Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …

News

Sandoz to acquire generic injectables business

May 28, 2009
Sales and Marketing generics

Sandoz, the generics arm of Novartis, is to acquire the generic injectables business of Austrian company EBEWE Pharma.The deal, which …

News

Pfizer signs Indian generic deals

May 21, 2009
Sales and Marketing Pfizer, generics

Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026